Open access
80
Views
16
CrossRef citations to date
0
Altmetric
Original Research
Use of a 4-week up-titration regimen of roflumilast in patients with severe COPD
Henrik Watz1 Pulmonary Research Institute at LungenClinic Grosshansdorf, Airway Research Center North, German Center for Lung Research, Grosshansdorf, GermanyCorrespondence[email protected]
, Nitin Bagul2 DNA Medical Ltd, Langley, UK
, Klaus F Rabe3 Department of Pulmonary Medicine, LungenClinic Grosshansdorf, Airway Research Center North, German Center for Lung Research, Grosshansdorf;4 Department of Medicine, Christian Albrecht University Kiel, Kiel, Germany
, Stephen Rennard5 Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA;6 AstraZeneca, Cambridge, UK
, Vijay KT Alagappan7 AstraZeneca, Gaithersburg, MD, USA
, Jonas Román8 AstraZeneca R&D, Gothenburg, Sweden
, Axel Facius9 thinkQ2 AG, Baar, Switzerland
& Peter MA Calverley10 Department of Clinical Sciences, Institute of Ageing and Chronic Disease, University of Liverpool, Liverpool, UK
show all
Pages 813-822
|
Published online: 06 Mar 2018
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.